In addition, OMT decreases the expression levels of VEGF (125), TGF-β1, and PAI-1 proteins (126), and inhibits tumor micro-vessel formation, invasion, and metastatic potential in human pancreatic and colorectal cancers. Here, VEGFA is linked to neoplasm.